CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
Blood Draws Data Collectionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06047210
NCT06047210N/ACompleted
CompareCT.gov

An Observational, Multicenter Study to Evaluate Levels of Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Adult Patients With Hemophagocytic Lymphohistiocytosis (A-HLH)

Swedish Orphan Biovitrum·observational·Posted Sep 21, 2023·Updated Sep 19, 2024

In Brief

An observational study evaluating Blood Draws Data Collection for Hemophagocytic Lymphohistiocytoses. Completed, enrolled 14 participants across 1 site.

Detailed Summary

This observational study is designed to provide a better understanding of the potential use of interferon gamma (IFNγ) and IFNγ-inducible chemokines as markers of HLH disease activity in adults, and the potential of IFNγ to represent a therapeutic target.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemophagocytic Lymphohistiocytoses
CountriesUnited States
CollaboratorsBrigham and Women's Hospital, Harvard Medical School (HMS and HSDM)

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 21, 2023
Enrollment StartDec 14, 2016
Primary CompletionOct 30, 2019
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 2.8 years ago

Interventions

Blood Draws Data Collectionother